Literature DB >> 18928162

Neuropsychiatric lupus in patients with lupus glomerulonephritis.

Simeon Valentinov Monov1, Daniela Valentinova Monova.   

Abstract

Neuropsychiatric symptoms are recognized to occur in a significant percentage of systemic lupus erythematosus patients and to be a leading cause of morbidity and mortality in lupus. The aim of the present study is to investigate neuropsychiatric symptoms in the patients with lupus nephritis without chronic renal failure. We studied 74 patients (4 male, 70 female) with SLE without chronic renal failure. Disease activity was assessed by the European Consensus Lupus activity Measurement (ECLAM). Renal biopsies disclosed type V lesions in 23 patients, type IV--in 34, type III--in 3, type II--in 11, type I--in 3 patients. Two control groups are used--with rheumatoid arthritis (96 patients) and 63 healthy subjects. The most frequent clinical manifestations are cognitive dysfunction (52.94%), headache (29.41%), psychoses (17.65%), epileptic seizures (20.59%) etc., and the most common cognitive deficit is related to impairment of the memory. The tests for cognitive disorders and nuclear magnetic resonance are the methods of investigation, by which the nervous system injuries are most early detected in the course of the disease. The presented study describes the correlations between the immunologic deviations (antiribosomal P-antibodies, aPL, aSm, aC1q), MMP-9, AT III and the NP injuries.

Entities:  

Mesh:

Year:  2007        PMID: 18928162

Source DB:  PubMed          Journal:  Med Pregl        ISSN: 0025-8105


  2 in total

1.  Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients.

Authors:  Eleni I Kampylafka; Haralampos Alexopoulos; Michalis L Kosmidis; Demosthenes B Panagiotakos; Panayiotis G Vlachoyiannopoulos; Marinos C Dalakas; Haralampos M Moutsopoulos; Athanasios G Tzioufas
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

2.  Silent cerebral MRI findings in lupus nephritis patients: Is it clinically significant?

Authors:  Mohamed A Hussein; Yumn A Elsabagh; Ahmed Hosny; Hala Elgendy
Journal:  J Adv Res       Date:  2017-11-20       Impact factor: 10.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.